Tag Archives: Approved

oneM2M specifications approved by more than 190 ITU member countries as ITU standard to simplify IoT adoption

More than 190 ITU-T member countries have approved oneM2M specifications as ITU standard, simplifying the IoT ecosystem lifecycle by minimizing development, deployment, and maintenance costs. The ITU-T’s SG20 Internet of Things (IoT) and smart cities and communities (SC&C) approved oneM2M’s security specifications for IoT systems as part of the ITU-T Y.4500.3 series, making the entire… Read More »

Approved protein shakes for hcg diet

You can use this occasionally they love their protein shakes foe others opt for this on the calorie protein. Other secrets to prevent hunger the original HCG shakes protocol developed by Dr. Human chorionic gonadotropin is a just like when hcg are in for hurry but not uterus. Some simply want this approved. If you… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »

Coronavirus vaccine: Treatment approved for use by NHS – ‘Thousands of lives to be saved’

Coronavirus has killed more than 40,000 people in the UK, with the number continuing to rise. But, scientists have made a breakthrough in the search for a COVID-19 vaccine. The NHS has been backed to immediately use the dexamethasone steroid as a treatment for coronavirus. The drug has been revealed to lower the risk of… Read More »

Ofev Approved for Chronic Fibrosing ILDs With Progressive Phenotype

TUESDAY, March 10, 2020 — Ofev (nintedanib) oral capsules have received the first approval for the treatment of patients with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype, the U.S. Food and Drug Administration announced Monday. Ofev, a multitargeted tyrosine kinase inhibitor, was approved in 2014 to treat idiopathic pulmonary fibrosis and to… Read More »

Lynparza (olaparib) Approved in the US as a First-Line Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer

Print this page 30 December 2019 — AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., US (Merck: known as MSD outside the US and Canada) today announced that Lynparza® (olaparib) has been approved in the US for the maintenance treatment of adult patients with deleterious or suspected deleterious germline BRCA-mutated (gBRCAm) metastatic pancreatic adenocarcinoma whose… Read More »

American Medical Association calls for total ban of non-FDA approved vaping products

A woman smokes an E-Cigarette at Digital Ciggz in San Rafael, California. Justin Sullivan | Getty Images The American Medical Association called for a total ban on all vaping products that haven’t been approved by the Food and Drug Administration to help quit smoking, the nation’s largest association of physicians announced Tuesday. “The recent lung… Read More »